| Tag | Content |
|---|
EnhancerAtlas ID | HS108-16935 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr17:41162340-41163170 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2A | MA0052.3 | chr17:41162688-41162700 | GCTAAAAATAGA | + | 6.92 | | MEF2B | MA0660.1 | chr17:41162688-41162700 | GCTAAAAATAGA | + | 6.44 | | MEF2C | MA0497.1 | chr17:41162686-41162701 | CTGCTAAAAATAGAA | + | 7.06 | | POU4F2 | MA0683.1 | chr17:41162619-41162635 | ATGAATAACTAATGAT | + | 6.23 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35535 | chr17:41161771-41164515 | HepG2 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I043010 | chr17 | 41162142 | 41164362 |
|
Enhancer Sequence | TCGAGGCTGC AGTGAGCCAT AATGGAGCAA TTGCACTCCA GCCTGGGTGG CATTGAGACT 60
TTGTCTCAAA AAACAAAACA AAACAAAAAC ATGGGTAGAT TTGCTGTGGG GGGAAACTTT 120
GTTATGGCTA GAAGCAGTTT ACTTTAGAAA GGACATGCTC TTCCCAGTGC GTCAGAGTCC 180
CCACCACTCT CTGTTATCCT ACATGGCTCT ATTAACTCAT TAATGTCATC CAACTGGCCC 240
TTAAAGGCAC TGTGTTAGCA CTCTCTGAGT TACAGAAATA TGAATAACTA ATGATCTTTT 300
TCACTATTCA TAAACCAGCA TAATTTGGTC AAGCTCTAGT ATTCTTCTGC TAAAAATAGA 360
ACAAACTCAC ACTGAATTTC TTTGGTGTCC TCTGTAATGT GCTCCTTTAC CGTCATTCAT 420
TCACTTCATT TCTTCATTCA ACACAGTTTT ACCGGACACA TATTTTGTGC CGGAGATCTT 480
GCTGGACACA AGGAATACAG AGATGGTCAG AACAGAGTCC TATCTTTCCA AGAGATCTCA 540
TGCTTCTCTG AGCTGAACTT CTTTATCAGG ATTCCTAACC ACAGGGTGAA CTCTGCTCTA 600
TTCCACAAAC AAAGGTGCAT TTATTGGTAT CCCTGGTGTC ACTTCCCTGC CTGTGATGTC 660
AGTTCTCTCT CTGGACCCAT TCCAGATCAC ACCCAGCCTA AAAGGTTACT TGGTGTACAG 720
TGGAAAGTGT GACAGTCCAG GGACAAGCTA GAATTGATGG GTAAACTACC TCCCCACTCT 780
GGGCTTCATT TCTTCACTGT AAAGCACAGG TTAGTGGGTG GGCTCTGGAG 830
|
